SYNLAB AG
SYAB.DE
$-0.02
Change (1 day)
$13.11
Year High
$8.46
Year Low
Categories
SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers Coronavirus tests, and medical and veterinary diagnostics services. It operates through approximately 500 laboratories and 1,800 blood collection points in 36 countries in four continents. The company was founded in 1998 and is headquartered in Munich, Germany.
Earnings for SYNLAB AG (SYAB.DE)
Earnings in 2023 (TTM): $150.9 M
According to SYNLAB AG's latest financial reports the company's current earnings (TTM) are $150.9 M. The earnings displayed on this page is the company's Pretax Income.
Earnings history of SYNLAB AG
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $150.9 M | $97.34 M |
| 2022 | $298.52 M | $158.97 M |
| 2021 | $849.87 M | $659.07 M |
| 2020 | $132.13 M | $40.02 M |
| 2019 | $-99,815,631 | $-128,558,777 |
| 2018 | $-20,586,578 | $-54,083,151 |
| 2017 | $-152,858,641 | $-174,665,751 |
| 2016 | $-213,883,103 | $-243,052,433 |
| 2015 | $-162,439,365 | $-178,154,520 |